Delaying ADT Safe for Prostate Cancer Patients | Cancer Network

Delaying ADT Safe for Prostate Cancer Patients | Cancer Network

The estimated 5-year overall survival among the group of men who had delayed ADT was 87.2% compared with 85.1% for those who had immediate ADT following a PSA-based relapse. Ten-year survival was 71.6% for both groups.

The prostate cancer-specific mortality was also similar for the two groups: the 5-year survival for the immediate and delayed ADT groups was 96% and 93.3%, respectively, and the 10-year survival was 90.2% and 89.4%, respectively. All of the patients were previously treated with radical prostatectomy or radiotherapy......

....

Related articles

• Prostate Cancer Patients Who Opt for ADT Should also Undergo Counseling for Improving Mental and Emotional Well-Being
• When undergoing androgen deprivation therapy, prostate cancer patients should be counseled to improve mental and emotional well-being
• Primary Androgen-Deprivation Therapy Has No Survival Benefit in Cancers Confined to Prostate
• Memory, thinking, concentration, and ADT for prostate cancer
• Surgery better than radiation, hormone treatments for some prostate cancer, study shows
• Steve Joyce: Popular ADT Prostate Cancer Treatment Associated with Bone Decay